SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen, Theresa J. Ngai, Sharianne G. Louie, Kevin W.H. Yee, Lily M. Wong, Weiru Hong, Leslie B. Lee, Ajia Town, Beverly D. Smolich, William C. Manning, Lesley J. Murray, Michael C. Heinrich, Julie M. Cherrington

Research output: Contribution to journalArticlepeer-review

766 Scopus citations

Fingerprint

Dive into the research topics of 'SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds